[Addressing the cancer invasion in non-alcoholic steatohepatitis].
Nonalcoholic steatohepatitis (NASH) may progress to end-stage liver disease, and needs medical intervention. Hepatocellular carcinoma (HCC) may occur in patients with NASH prior to occurrence of cirrhosis. There is paucity of knowledge in understanding how NASH progresses to HCC. The present overview intends to provide updates in clinical and basic research of NASH-HCC, challenges and strategies in understanding its pathogenesis and solutions to increased incidence.